Leerink Partners Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $28

Futu NewsOct 25 23:34 · Ratings

Solid Biosciences: Buy Rating Reaffirmed Amid Market Skepticism and Upcoming SGT-003 Data Release

TipRanksOct 25 23:16 · Ratings

Capricor Reports Positive Long-term Data for DMD Drug Deramiocel

Seeking AlphaOct 12 00:41

Capricor Stock Rallies 20% on DMD Data Presentation Update

Seeking AlphaOct 5 01:33

Piper Sandler Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $20

Futu NewsOct 4 20:31 · Ratings

Solid Biosciences (SLDB) Gets a Buy From Piper Sandler

TipRanksOct 4 20:07 · Ratings